Potential implications of increased utilization of oral nirmatrelvir/ritonavir in outpatient care for COVID-19: modeled findings from the Spanish National Health System perspective.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42287108

Alfonso de Lossada; Carmen Peral; Jackie Lee; Jennifer Benner; Laura Cianciolo; Matthew Sussman; Tendai Mugwagwa

Jun 14, 2026